Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × OTHER × Tetanus × Clear all

Phase

Status

Recruiting 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 616 Neoplasms 399 Prostatic Neoplasms 343 Carcinoma, Non-Small-Cell Lung 333 Lung Neoplasms 270 Leukemia, Myeloid, Acute 264 Multiple Myeloma 236 Neoplasm Metastasis 212 Pancreatic Neoplasms 210 Leukemia 209 Colorectal Neoplasms 200 Precursor Cell Lymphoblastic Leukemia-Lymphoma 184 Melanoma 182 Lymphoma 181 Brain Neoplasms 170 Recurrence 152 Lymphoma, Non-Hodgkin 151 Myelodysplastic Syndromes 149 Head and Neck Neoplasms 149 Leukemia, Lymphocytic, Chronic, B-Cell 147 Ovarian Neoplasms 139 Carcinoma, Hepatocellular 133 Glioblastoma 131 Carcinoma, Renal Cell 116 Rectal Neoplasms 112 Lymphoma, Follicular 109 Lymphoma, Large B-Cell, Diffuse 106 Colonic Neoplasms 103 Hodgkin Disease 101 Glioma 96

Interventions

sargramostim 1 Temozolomide 1 Granulocyte-Macrophage Colony-Stimulating Factor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03927222 2024-04-08

I-ATTAC

Duke University

Phase 2 Terminated

6 enrolled 7 charts

Glioblastoma, Tetanus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡